- Home
- RMBI vs DTIL Comparison
RMBI vs DTIL Comparison
Compare RMBI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMBI | DTIL |
|---|---|---|
| Founded | 1887 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.1M | 128.8M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RMBI | DTIL |
|---|---|---|
| Price | $13.25 | $5.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 17.0K | ★ 180.7K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.51% | N/A |
| EPS Growth | ★ 1.10 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | N/A | ★ $1,070,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | $16.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.80 | $3.53 |
| 52 Week High | $15.24 | $8.82 |
Technical Indicators
Market Signals| Indicator | RMBI | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 32.85 | 73.04 |
| Support Level | $13.02 | $4.50 |
| Resistance Level | $14.31 | $5.80 |
| Average True Range (ATR) | 0.35 | 0.36 |
| MACD | -0.08 | 0.16 |
| Stochastic Oscillator | 13.53 | 79.86 |
Price Performance
Historical ComparisonAbout RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.